Fidaxomicin Interactions
Showing entire list of all interactions, including brand names and combination drugs.
Go back to interactions summary
Medications known to interact with fidaxomicin
B
- Baby Probiotic Colic Drops (lactobacillus rhamnosus)
- Bacid (LAC) (lactobacillus acidophilus)
- bacillus coagulans / calcium carbonate
- bacillus coagulans / inulin
- Balversa (erdafitinib)
- BD Lactinex (lactobacillus acidophilus / lactobacillus bulgaricus)
- Belsomra (suvorexant)
- bepridil
- berotralstat
- betrixaban
- Bevyxxa (betrixaban)
- Biaxin (clarithromycin)
- Biaxin XL (clarithromycin)
- bictegravir / emtricitabine / tenofovir alafenamide
- bifidobacterium animalis / cholecalciferol / lactobacillus rhamnosus gg
- bifidobacterium animalis / lactobacillus rhamnosus
- bifidobacterium infantis
- bifidobacterium infantis / bifidobacterium lactis / streptococcus thermophilus
- bifidobacterium infantis / lactobacillus acidophilus
- bifidobacterium infantis / lactobacillus acidophilus / streptococcus thermophilus
- Bijuva (estradiol / progesterone)
- Biktarvy (bictegravir / emtricitabine / tenofovir alafenamide)
- binimetinib
- Bio-K+ (lactobacillus acidophilus / lactobacillus casei / lactobacillus rhamnosus)
- Bio-K+ Extra Strength (lactobacillus acidophilus / lactobacillus casei / lactobacillus rhamnosus)
- Bio-K+ Regular (lactobacillus acidophilus / lactobacillus casei / lactobacillus rhamnosus)
- Bio-K+ Strong (lactobacillus acidophilus / lactobacillus casei / lactobacillus rhamnosus)
- BioGaia (lactobacillus reuteri)
- BioGaia ProTectis (cholecalciferol / lactobacillus reuteri)
- boceprevir
- Bosulif (bosutinib)
- bosutinib
- Braftovi (encorafenib)
- brigatinib
- Brilinta (ticagrelor)
More about fidaxomicin
- fidaxomicin consumer information
- Check interactions
- Compare alternatives
- Reviews (19)
- Side effects
- Dosage information
- During pregnancy
- Drug class: macrolides
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.